J A F Koekkoek
Overview
Explore the profile of J A F Koekkoek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oort Q, Reijneveld J, Sikkes S, Koekkoek J, Boele F, Young T, et al.
Eur J Cancer
. 2024 Sep;
212:114335.
PMID: 39332215
Background: Neurocognitive impairments are common in patients with a brain tumour, and may negatively impact on functioning in daily life, particularly on instrumental activities of daily living (IADL). The EORTC...
2.
Kerkhof M, Koekkoek J, Vos M, van den Bent M, Taal W, Postma T, et al.
J Neurooncol
. 2019 Feb;
142(3):463-470.
PMID: 30778733
Background: When glioma patients experience long-term seizure freedom the question arises whether antiepileptic drugs (AEDs) should be continued. As no prospective studies exist on seizure recurrence in glioma patients after...
3.
Koekkoek J, Dirven L, Sizoo E, Pasman H, Heimans J, Postma T, et al.
J Neurooncol
. 2014 Aug;
120(3):589-95.
PMID: 25151506
During the end of life (EOL) phase of high-grade glioma (HGG) patients, care is primarily aimed at reducing symptom burden while maintaining quality of life as long as possible. In...
4.
Koekkoek J, Dirven L, Reijneveld J, Sizoo E, Pasman H, Postma T, et al.
J Neurooncol
. 2014 Jul;
120(2):303-10.
PMID: 25038849
Exploring cross-national differences is useful to evaluate whether different patterns of end of life (EOL) care meet patient's specific needs. This study aimed to (1) compare EOL care processes for...
5.
Koekkoek J, Pieters T
Ned Tijdschr Geneeskd
. 2009 Jan;
152(51-52):2810-6.
PMID: 19177923
The history of the treatment ofbrain tumours in the Netherlands begins around 1890. From this time up to 1950, following other European countries and later the United States, the conceptualization,...